The Gene Editing Dilemma: Where Science Meets Society | Chloe Richards | TEDxKings College School

Quick Overview

Chloe Richards argues that the technique of germline gene editing, exemplified by the CRISPR-Cas9 system used to disable the CCR5 gene in twin girls to confer HIV resistance, carries significant ethical and societal risks, such as creating a two-tiered society and potentially passing on harmful mutations, necessitating a global conversation on responsible technological application rather than an outright ban.

Key Points: The speaker discusses the 2018 case where scientist He Jiankui used gene editing (CRISPR-Cas9) to disable the CCR5 gene in twin girls (Lulu and Nana) to protect them from HIV. This editing targeted mitochondrial DNA, which is inherited only through the mother's egg cell, meaning the modification would not be passed down through sperm. The 23-page document submitted by Jiankui was written in English, not his native language, suggesting a lack of fully considered context or ethical grounding. A UK survey indicated that 76% of the British population thought germline gene editing was reckless or ethically indefensible. The speaker questions whether society should use this technology for enhancement, risking a two-tiered society of edited and unedited individuals, rather than just for treating diseases like HIV or Huntington's. Mitochondrial Replacement Therapy (MRT) is presented as a more ethically accepted form of gene editing used for treating mitochondrial diseases. The core message is that society must have a conversation about using this powerful technology responsibly before widespread application occurs.

Context: Chloe Richards delivers a TEDx talk at King's College School discussing the ethical and societal implications of germline gene editing, specifically referencing the controversial 2018 experiment by He Jiankui who used CRISPR-Cas9 technology to modify the genes of twin girls to attempt to make them resistant to HIV, prompting a necessary public debate on the technology's future use.

Detailed Analysis

Chloe Richards opens by referencing the controversial 2018 event where He Jiankui genetically modified human embryos using CRISPR-Cas9 to disable the CCR5 gene, aiming to confer HIV resistance to twin girls, Lulu and Nana. Richards notes that Jiankui's extensive 23-page document detailing the work was written in English, suggesting a potential lack of deep consultation. She highlights that this specific modification targeted mitochondrial DNA from the mother's egg cell, meaning the change would not be passed through sperm, but emphasizes the ethical concerns surrounding germline editing in general. A survey revealed that 76% of the British public considered this application reckless or ethically indefensible. Richards contrasts this with Mitochondrial Replacement Therapy (MRT), which is more ethically accepted for treating diseases caused by faulty mitochondrial DNA. She argues that the technology’s power forces society to address difficult questions: Should gene editing be used for enhancement, potentially creating a society split between the edited and unedited? She urges the audience to engage in conversation about the responsible use of this technology, rather than simply banning it, as such powerful tools will inevitably exist.